183 related articles for article (PubMed ID: 12444549)
21. The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo.
Nguyen ML; Nguyen MM; Lee D; Griep AE; Lambert PF
J Virol; 2003 Jun; 77(12):6957-64. PubMed ID: 12768014
[TBL] [Abstract][Full Text] [Related]
22. Design of a PDZbody, a bivalent binder of the E6 protein from human papillomavirus.
Karlsson OA; Ramirez J; Öberg D; Malmqvist T; Engström Å; Friberg M; Chi CN; Widersten M; Travé G; Nilsson MT; Jemth P
Sci Rep; 2015 Mar; 5():9382. PubMed ID: 25797137
[TBL] [Abstract][Full Text] [Related]
23. HPV oncoprotein E6 is a structure-dependent DNA-binding protein that recognizes four-way junctions.
Ristriani T; Masson M; Nominé Y; Laurent C; Lefevre JF; Weiss E; Travé G
J Mol Biol; 2000 Mar; 296(5):1189-203. PubMed ID: 10698626
[TBL] [Abstract][Full Text] [Related]
24. Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase.
Nakagawa S; Huibregtse JM
Mol Cell Biol; 2000 Nov; 20(21):8244-53. PubMed ID: 11027293
[TBL] [Abstract][Full Text] [Related]
25. Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein.
Kiyono T; Hiraiwa A; Fujita M; Hayashi Y; Akiyama T; Ishibashi M
Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11612-6. PubMed ID: 9326658
[TBL] [Abstract][Full Text] [Related]
26. Kinetic analysis of the interactions of human papillomavirus E6 oncoproteins with the ubiquitin ligase E6AP using surface plasmon resonance.
Zanier K; Charbonnier S; Baltzinger M; Nominé Y; Altschuh D; Travé G
J Mol Biol; 2005 Jun; 349(2):401-12. PubMed ID: 15890204
[TBL] [Abstract][Full Text] [Related]
27. Degradation of hDlg and MAGIs by human papillomavirus E6 is E6-AP-independent.
Grm HS; Banks L
J Gen Virol; 2004 Oct; 85(Pt 10):2815-2819. PubMed ID: 15448342
[TBL] [Abstract][Full Text] [Related]
28. Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein.
Lee SS; Weiss RS; Javier RT
Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6670-5. PubMed ID: 9192623
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of E6-induced degradation of its cellular substrates by novel blocking peptides.
Sterlinko Grm H; Weber M; Elston R; McIntosh P; Griffin H; Banks L; Doorbar J
J Mol Biol; 2004 Jan; 335(4):971-85. PubMed ID: 14698292
[TBL] [Abstract][Full Text] [Related]
30. Role of the PDZ domain-binding motif of the oncoprotein E6 in the pathogenesis of human papillomavirus type 31.
Lee C; Laimins LA
J Virol; 2004 Nov; 78(22):12366-77. PubMed ID: 15507623
[TBL] [Abstract][Full Text] [Related]
31. Human Papillomavirus 16 (HPV-16), HPV-18, and HPV-31 E6 Override the Normal Phosphoregulation of E6AP Enzymatic Activity.
Thatte J; Banks L
J Virol; 2017 Nov; 91(22):. PubMed ID: 28835500
[TBL] [Abstract][Full Text] [Related]
32. E6AP-dependent degradation of DLG4/PSD95 by high-risk human papillomavirus type 18 E6 protein.
Handa K; Yugawa T; Narisawa-Saito M; Ohno S; Fujita M; Kiyono T
J Virol; 2007 Feb; 81(3):1379-89. PubMed ID: 17121805
[TBL] [Abstract][Full Text] [Related]
33. Targeting the Two Oncogenic Functional Sites of the HPV E6 Oncoprotein with a High-Affinity Bivalent Ligand.
Ramirez J; Poirson J; Foltz C; Chebaro Y; Schrapp M; Meyer A; Bonetta A; Forster A; Jacob Y; Masson M; Deryckère F; Travé G
Angew Chem Int Ed Engl; 2015 Jun; 54(27):7958-62. PubMed ID: 26014966
[TBL] [Abstract][Full Text] [Related]
34. Comparison of p53 and the PDZ domain containing protein MAGI-3 regulation by the E6 protein from high-risk human papillomaviruses.
Ainsworth J; Thomas M; Banks L; Coutlee F; Matlashewski G
Virol J; 2008 Jun; 5():67. PubMed ID: 18518978
[TBL] [Abstract][Full Text] [Related]
35. PDZ domains and viral infection: versatile potentials of HPV-PDZ interactions in relation to malignancy.
Nagasaka K; Kawana K; Osuga Y; Fujii T
Biomed Res Int; 2013; 2013():369712. PubMed ID: 24093094
[TBL] [Abstract][Full Text] [Related]
36. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation.
Crook T; Tidy JA; Vousden KH
Cell; 1991 Nov; 67(3):547-56. PubMed ID: 1657399
[TBL] [Abstract][Full Text] [Related]
37. The hScrib/Dlg apico-basal control complex is differentially targeted by HPV-16 and HPV-18 E6 proteins.
Thomas M; Massimi P; Navarro C; Borg JP; Banks L
Oncogene; 2005 Sep; 24(41):6222-30. PubMed ID: 16103886
[TBL] [Abstract][Full Text] [Related]
38. Specific recognition of four-way DNA junctions by the C-terminal zinc-binding domain of HPV oncoprotein E6.
Ristriani T; Nominé Y; Masson M; Weiss E; Travé G
J Mol Biol; 2001 Jan; 305(4):729-39. PubMed ID: 11162088
[TBL] [Abstract][Full Text] [Related]
39. Human and primate tumour viruses use PDZ binding as an evolutionarily conserved mechanism of targeting cell polarity regulators.
Tomaić V; Gardiol D; Massimi P; Ozbun M; Myers M; Banks L
Oncogene; 2009 Jan; 28(1):1-8. PubMed ID: 18820705
[TBL] [Abstract][Full Text] [Related]
40. High-risk human papillomavirus E6 oncoproteins interact with 14-3-3ζ in a PDZ binding motif-dependent manner.
Boon SS; Banks L
J Virol; 2013 Feb; 87(3):1586-95. PubMed ID: 23175360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
